Basolateral Amygdala (Bla) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Basolateral Amygdala (BLA) is the principal input station for cortical and thalamic information to the amygdala, critical for fear learning, reward processing, and emotional memory consolidation. BLA neurons are heavily implicated in the neuropsychiatric symptoms of neurodegenerative diseases.
| Property | Value |
|---|---|
| Cell Type Name | Basolateral Amygdala (BLA) Neurons |
| Location | Dorsal-lateral amygdala, includes lateral (LA), basal (BA), and accessory basal (AB) nuclei |
| Neurotransmitter | Glutamate (principal), GABA (interneurons) |
| Lineage | Glutamatergic neuron > cortical-like excitatory neuron |
| Marker Genes | SLC17A7 (VGLUT1), SLC17A6 (VGLUT2), CaMKIIa, CTB5, BDNF, RGS14 |
| Brain Regions | Hippocampus, Prefrontal Cortex, Sensory Cortices, Striatum |
BLA principal neurons have distinctive features:
The Basolateral Amygdala processes emotional salience:
Key markers in BLA neurons:
| Gene | Expression | Function |
|---|---|---|
| SLC17A7 (VGLUT1) | Very High | Vesicular glutamate transport |
| CaMKIIa | High | Calcium-dependent kinase |
| BDNF | High | Neurotrophin |
| RGS14 | High | BLA-enriched regulator |
| PDE4B | Moderate | Phosphodiesterase |
| FOS | Activity-dependent | Immediate early gene |
| NR2A/NR2B | Moderate | NMDA receptor subunits |
The study of Basolateral Amygdala (Bla) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155-184. PMID:10845062 ↩︎
McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci. 2004;27:1-28. PMID:15217323 ↩︎
Balleine BW, Killcross S. Parallel incentive processing: an integrated view of amygdala function. Trends Neurosci. 2006;29(5):272-279. PMID:16545468 ↩︎
Paton JJ, Belova MA, Morrison SE, Salzman CD. The primate amygdala represents the negative but not positive aspects of a stimulus during appetitive conditioning. Learn Mem. 2006;13(6):837-846. PMID:17142307 ↩︎
Tye KM, Prakash R, Kim SY, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471(7338):358-362. PMID:21389985 ↩︎
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(3):389-404. PMID:16906426 ↩︎
Forster MJ, Neeper SE. Neurobehavioral effects of cholinergic and GABAergic lesions in the amygdala. Brain Res. 2000;857(1-2):45-55. PMID:10700553 ↩︎
视听 M, Brown MW, Aggleton JP. What do the basal amygdala and bed nucleus of the stria terminalis contribute to emotional processing? Brain Res. 2015;1617:1-14. PMID:25432075 ↩︎
Lyketsos CG, et al. Neuropsychiatric symptoms in Alzheimer's disease. Int Psychogeriatr. 2000;12(1):131-137. PMID:10875140 ↩︎
Taylor JP, et al. Anxiety and depression in Parkinson's disease. Int J Geriatr Psychiatry. 2006;21(3):209-213. PMID:16534774 ↩︎
Aarsland D, et al. Depression in Parkinson disease. Epidemiology, pathophysiology, and management. Drugs. 2010;70(5):545-560. PMID:20329802 ↩︎
Voon V, et al. Impulse control disorders in Parkinson disease. Ann Neurol. 2011;69(6):986-996. PMID:21416496 ↩︎
van der Staay FJ, et al. The basolateral amygdala in neuropsychiatric disease. J Neural Transm. 2009;116(11):1459-1472. PMID:19669699 ↩︎
Herges S, et al. Altered fear conditioning in Huntington's disease. Behav Brain Res. 1999;99(2):123-132. PMID:10515583 ↩︎
Duff K, et al. Psychiatric symptoms in Huntington's disease. Biol Psychiatry. 2007;62(12):1341-1346. PMID:17481592 ↩︎
Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of PTSD and functional neuroimaging. Ann N Y Acad Sci. 2006;1071:176-189. PMID:16891573 ↩︎
Gorman JM, Kent JM. Anxiety and panic: brain mechanisms and treatment. J Clin Psychiatry. 2000;61(8):607-614. PMID:10968850 ↩︎
Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders. Nat Med. 2007;13(11):1283-1290. PMID:17982454 ↩︎
Davis M, et al. Effects of diazepam on conditioned fear. J Neurosci. 1994;14(5):2683-2691. PMID:8182435 ↩︎
Zorrilla EP, Koob GF. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today. 2010;15(9-10):371-383. PMID:20363170 ↩︎
Milad MR, Quirk GJ. Fear extinction as a conserved memory system. Nat Rev Neurosci. 2012;13(12):836-843. PMID:23117363 ↩︎